Meyka Pro banner
Harte Hanks, Inc.

Harte Hanks, Inc. (NASDAQ: HHS) Stock Competitors & Peer Comparison

See HHS's competitors and their performance on the NASDAQ and across the wider stock market.

HHSNASDAQ
IndustrialsSpecialty Business Services
$4.24
$0.02(0.47%)
U.S. Market is Open · 11:06

Peer Comparison Table: Specialty Business Services Industry

Detailed financial metrics including price, market cap, P/E ratio, and more for HHS and its NASDAQ peers.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
HHS$4.27+1.43%31.7M-5.62-$0.76N/A
CTAS$200.47-0.29%80.2B40.58$4.94+0.93%
RELX$35.51-3.11%62B20.79$1.71+2.57%
TRI$105.68-5.44%46.1B25.53$4.14+3.79%
CPRT$33.72+0.42%31.2B20.94$1.61N/A
ROL$35.86+0.42%17.3B31.46$1.14+2.04%
RBA$83.54+0.32%15.6B19.99$4.18+1.51%
ARMK$56.78-0.87%14.9B27.83$2.04+0.85%
ULS$73.83-1.07%14.8B33.87$2.18+0.77%
BIPI$16.47+0.30%13.1BN/AN/A+7.78%
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

Cintas Corporation (NASDAQ: CTAS)

HHS vs CTAS Comparison September 2026

Harte Hanks, Inc. (NASDAQ: HHS) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HHS stands at 31.7M. In comparison, CTAS has a market cap of 80.2B. Regarding current trading prices, HHS is priced at $4.27 on the NASDAQ, while CTAS trades at $200.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HHS currently has a P/E ratio of -5.62, whereas CTAS's P/E ratio is 40.58. In terms of profitability, HHS's ROE is -0.30%, compared to CTAS's ROE of +0.42%. Regarding short-term risk, HHS is more volatile compared to CTAS. This indicates higher risk in terms of short-term price fluctuations for HHS.Check CTAS's competition here

Stock price comparison of stocks in the Industrials Sector

Loading...

Frequently Asked Questions